The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Open accessAbstract
Recently, we demonstrated a significant increase of an oxidized nucleoside derived from RNA, 8-hydroxyguanosine (8OHG), and an oxidized amino acid, nitrotyrosine in vulnerable neurons of patients with Alzheimer disease (AD). To determine whether oxidative damage is an early- or end-stage event in the process of neurodegeneration in AD, we investigated the relationship between neuronal 8OHG and nitrotyrosine and histological and clinical variables, i.e. amyloid-beta (A beta) plaques and neurofibrillary tangles (NFT), as well as duration of dementia and apolipoprotein E (ApoE) genotype. Our findings show that oxidative damage is quantitatively greatest early in the disease and reduces with disease progression. Surprisingly, we found that increases in A beta deposition are associated with decreased oxidative damage. These relationships are more significant in ApoE epsilon4 carriers. Moreover, neurons with NFT show a 40%-56% decrease in relative 8OHG levels compared with neurons free of NFT. Our observations indicate that increased oxidative damage is an early event in AD that decreases with disease progression and lesion formation. These findings suggest that AD is associated with compensatory changes that reduce damage from reactive oxygen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Past and recent studies have demonstrated that oxidative damage is not only an early event in the pathogenesis of AD, occurring before the onset of clinical symptoms but also a factor contributing to the disease progression [17,18,19,20,21].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [19]
In the citing paper
“In the brains of individuals with AD and preclinical AD (i.e., evidence of Aβ and tau deposition in the brain without any clinical manifestation of the disease), as well as patients with MCI (a mild clinical impairment with no proof of underlying pathology with biomarkers), many oxidative damage products are measured, and numerous investigations have pointed to OS as a key and early player in the”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [19]
In the citing paper
“In the AD brain, mitochondria can be sources of ROS and also the target of OS, especially mitochondrial DNA (mtDNA) is susceptible to oxidative damage [19,53,63].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [19]
In the citing paper
“Oxidative damage to RNA in EC, hippocampus, subiculum, and temporal neocortex of subjects with AD has been described. The levels of 8-OHdG increase early before pathological changes occur, and this can explain that the selective vulnerability of neurons in the EC during AD may be related to the vulnerability of these particular neurons to oxidative damage [19].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Theory and Practice of Histological Techniques
Bancroft, J. D., & Gamble, M. (1990) · Cited by 6,948
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Mitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367
Self-citationReiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Research works printed but not linked: 2
- Smith, 1998, ApoE: Isoform specific antioxidant activity [abstract], Neurobiol Aging, 19, S222
- Nunomura, 2000, Increasing amyloid ß 42 deposition is associated with decreasing neuronal RNA oxidation in Down's syndrome and familial Alzheimer's disease [abstract], Brain pathol, 10, 783
Cited by
Sorted by citations
Items 701–800 of 1,005
Zatta, P. F., Tognon, G., & Carampin, P. (2003) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2003.00058.x · Cited by 64
Daulatzai, M. A. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1404-6 · Cited by 63
Human Polynucleotide Phosphorylase Protein in Response to Oxidative Stress
Hayakawa, H., & Sekiguchi, M. (2006) · Biochemistry · doi:10.1021/bi052585l · Cited by 63
Chakrabarti, S., Sinha, M., Thakurta, I. G., Banerjee, P., & Chattopadhyay, M. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990152 · Cited by 63
Prevention and Treatment of Alzheimer’s Disease: Biological Mechanisms of Exercise
McGurran, H., Glenn, J. M., Madero, E. N., & Bott, N. T. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180958 · Cited by 63
Cheng, H., Gang, X., Liu, Y., Wang, G., Zhao, X., & Wang, G. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00179.2019 · Cited by 63
Mitochondrial Permeability Transition: A Pore Intertwines Brain Aging and Alzheimer’s Disease
Jia, K., & Du, H. (2021) · Cells · doi:10.3390/cells10030649 · Cited by 63
New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer’s disease
Samanta, S., Akhter, F., Roy, A., Chen, D., Turner, B., Wang, Y., Clemente, N., Wang, C., Swerdlow, R. H., Battaile, K. P., et al. (2023) · Brain · doi:10.1093/brain/awad432 · Cited by 62
Foret, M. K., Orciani, C., Welikovitch, L. A., Huang, C., Cuello, A. C., & Carmo, S. D. (2024) · Communications Biology · doi:10.1038/s42003-024-06552-4 · Cited by 63
Stone, J. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.04.007 · Cited by 62
Twenty years of metallo-neurobiology: where to now?
Bush, A. I., & Curtain, C. C. (2007) · European Biophysics Journal · doi:10.1007/s00249-007-0228-1 · Cited by 62
Catalytic Antioxidants and Neurodegeneration
Golden, T. R., & Patel, M. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2256 · Cited by 62
Chiang, G. C.-Y., Mao, X., Kang, G., Chang, E., Pandya, S., Vallabhajosula, S., Isaacson, R., Ravdin, L., Initiative, A. D. N., & Shungu, D. C. (2017) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5143 · Cited by 62
Vida, C., de Toda, I. M., Garrido, A., Carro, E., Molina, J. A., & la Fuente, M. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01974 · Cited by 62
Alzheimer’s disease and Alzheimer’s dementia: distinct but overlapping entities
Blass, J. P. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00036-2 · Cited by 62
Aberrant localization of importin α1 in hippocampal neurons in Alzheimer disease
Lee, H., Ueda, M., Miyamoto, Y., Yoneda, Y., Perry, G. L., Smith, M. A., & Zhu, X. (2006) · Brain Research · doi:10.1016/j.brainres.2006.09.084 · Cited by 62
Self-citationKajitani, K., Yamaguchi, H., Dan, Y., Furuichi, M., Kang, D., & Nakabeppu, Y. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4948-05.2006 · Cited by 62
Strategies, Development, and Pitfalls of Therapeutic Options for Alzheimer's Disease
Haas, C. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110986 · Cited by 61
Lee, H. P., Pancholi, N., Esposito, L., Previll, L. A., Wang, X., Zhu, X., Smith, M. A., & Lee, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028033 · Cited by 61
Self-citationYao, J., Zhao, L., Mao, Z., Chen, S., Wong, K., To, J., & Brinton, R. D. (2013) · Brain Research · doi:10.1016/j.brainres.2013.02.021 · Cited by 61
The Role of Mitochondrial Dysfunction in the Progression of Alzheimer’s Disease
Desler, C., Lillenes, M. S., Tønjum, T., & Rasmussen, L. J. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170616110111 · Cited by 61
Cieślik, M., Czapski, G. A., Wójtowicz, S., Wieczorek, I., Wencel, P. L., Strosznajder, R. P., Jaber, V. R., Lukiw, W. J., & Strosznajder, J. B. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01819-y · Cited by 61
Olasehinde, T. A., Olaniran, A. O., & Okoh, A. I. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-03047-7 · Cited by 60
Vitamin D deficiency and Alzheimer disease: Common links
Keeney, J. T. R., & Butterfield, D. A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.06.020 · Cited by 60
Uddin, M. N., Afrin, R., Uddin, M. J., Uddin, M. J., Alam, A. K., Rahman, A. A., & Sadik, G. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0728-y · Cited by 60
Cervellati, C., Sticozzi, C., Romani, A., Belmonte, G., Rasmo, D. D., Signorile, A., Cervellati, F., Milanese, C., Mastroberardino, P. G., Pecorelli, A., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.07.014 · Cited by 60
Dual-function triazole–pyridine derivatives as inhibitors of metal-induced amyloid-β aggregation
Jones, M. R., Service, E. L., Thompson, J. R., Wang, M. C. P., Kimsey, I. J., DeToma, A. S., Ramamoorthy, A., Lim, M. H., & Storr, T. (2012) · Metallomics · doi:10.1039/c2mt20113e · Cited by 60
Wharton, S. B., O'Callaghan, J. P., Savva, G. M., Nicoll, J. A. R., Matthews, F. E., Simpson, J. E., Forster, G., Shaw, P. J., Brayne, C., & Ince, P. G. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000217729 · Cited by 60
Wilhelmus, M. M. M., van der Pol, S. M. A., Jansen, Q., Witte, M. E., van der Valk, P., Rozemüller, A. J. M., Drukarch, B., de Vries, H. E., & van Horssen, J. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.033 · Cited by 60
Three Dimensional Models of Cu 2+ -Aβ(1–16) Complexes from Computational Approaches
Alí‐Torres, J., Maréchal, J., Rodrı́guez-Santiago, L., & Sodupe, M. (2011) · Journal of the American Chemical Society · doi:10.1021/ja203407v · Cited by 60
Mondragón‐Rodríguez, S., Mena, R., Binder, L. I., Smith, M. A., Perry, G. L., & García‐Sierra, F. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00853.x · Cited by 60
Self-citationDiaz, Z., Assaraf, M. I., Miller, W. H., & Schipper, H. M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03038.x · Cited by 60
Oxidative Stress in Tauopathies: From Cause to Therapy
Bartolomé, F. B., Carro, E., & Alquézar, C. (2022) · Antioxidants · doi:10.3390/antiox11081421 · Cited by 59
Sporadic Alzheimer's Disease: The Starving Brain
Mamelak, M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120370 · Cited by 59
Aliev, G. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s2608 · Cited by 59
Self-citationSun, K.-H., Lee, H., Smith, M. A., & Shah, K. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-05-0433 · Cited by 59
Self-citationThe Role of Mitochondrial Impairment in Alzheimer´s Disease Neurodegeneration: The Tau Connection
Quntanilla, R. A., & Tapia-Monsalves, C. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200525020259 · Cited by 59
Mitochondria Are Related to Synaptic Pathology in Alzheimer′s Disease
Balogiannis, S. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/305395 · Cited by 58
Nithianantharajah, J., & Hannan, A. J. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.10.026 · Cited by 58
Johnstone, J., Nash, S., Hernandez, E., & Rahman, M. S. (2019) · Marine Environmental Research · doi:10.1016/j.marenvres.2019.05.017 · Cited by 58
Prevention of Cognitive Decline in Alzheimer’s Disease by Novel Antioxidative Supplements
Tadokoro, K., Ohta, Y., Inufusa, H., Loon, A. F. N., & Abe, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21061974 · Cited by 58
Picca, A., Guerra, F., Calvani, R., Coelho‐Júnior, H. J., Landi, F., Bernabei, R., Romanò, R., Bucci, C., & Marzetti, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.601740 · Cited by 58
Bar‐Am, O., Weinreb, O., Amit, T., & Youdim, M. B. H. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9139-6 · Cited by 58
Neurodegenerative Mechanisms in Subacute Sclerosing Panencephalitis
Hayashi, M., Arai, N., Satoh, J., Suzuki, H., Katayama, K., Tamagawa, K., & Morimatsu, Y. (2002) · Journal of Child Neurology · doi:10.1177/08830738020170101101 · Cited by 58
Nuclear and mitochondrial DNA oxidation in Alzheimer's disease
Santos, R. X., Correia, S. C., Zhu, X., Lee, H.-G., Petersen, R. B., Nunomura, A., Smith, M. A., Perry, G., & Moreira, P. I. (2012) · Free Radical Research · doi:10.3109/10715762.2011.648188 · Cited by 57
Self-citationChakrabarti, M., McDonald, A. J., Will Reed, J., Moss, M. A., Das, B. C., & Ray, S. K. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150450 · Cited by 57
Senescence-Accelerated Mice P8: A Tool to Study Brain Aging and Alzheimer's Disease in a Mouse Model
Pallàs, M. (2012) · ISRN Cell Biology · doi:10.5402/2012/917167 · Cited by 57
Heat-shock protein dysregulation is associated with functional and pathological TDP-43 aggregation
Chang, H., Hou, S., Way, T., Wong, C., & Wang, I. (2013) · Nature Communications · doi:10.1038/ncomms3757 · Cited by 57
Molecular Pathogenesis of Alzheimer’s Disease: Reductionist versus Expansionist Approaches
Castellani, R. J., Zhu, X., Lee, H., Smith, M. A., & Perry, G. L. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10031386 · Cited by 57
Self-citationSilva, D. E. S., Cali, M. P., Pazin, W. M., Carlos-Lima, E., Trevisan, M. T. S., Venâncio, T., Arcísio-Miranda, M., Ito, A. S., & Carlos, R. M. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01130 · Cited by 57
Nwidu, L. L., Elmorsy, E. M., Aprioku, J. S., Siminialayi, I., & Carter, W. G. (2018) · Medicines · doi:10.3390/medicines5030071 · Cited by 57
Iron stored in ferritin is chemically reduced in the presence of aggregating Aβ(1-42)
Everett, J. L., Brooks, J., Lermyte, F., O’Connor, P. B., Sadler, P. J., Dobson, J., Collingwood, J. F., & Telling, N. D. (2020) · Scientific Reports · doi:10.1038/s41598-020-67117-z · Cited by 57
Oxidative Stress and Microglial Response in Retinitis Pigmentosa
Murakami, Y., Nakabeppu, Y., & Sonoda, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197170 · Cited by 57
Antioxidant strategies in protection against neurodegenerative disorders
Tan, D.-X., Manchester, L. C., Sainz, R. M., Mayo, J. C., Alvares, F. L., & Reiter, R. J. (2003) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.13.10.1513 · Cited by 57
Chen, C.-H., Pan, C., Chen, C., & Huang, M. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01349.x · Cited by 57
Simpson, J. E., Ince, P. G., Matthews, F. E., Shaw, P. J., Heath, P. R., Brayne, C., Garwood, C., Higginbottom, A., Wharton, S. B., & MRC Cognitive Function and Ageing Neuropathology Study Group (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12202 · Cited by 56
The Potentials of Methylene Blue as an Anti-Aging Drug
Xue, H., Thaivalappil, A., & Cao, K. (2021) · Cells · doi:10.3390/cells10123379 · Cited by 56
Tabner, B. J., Mayes, J., & Allsop, D. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2011/546380 · Cited by 56
Oxidative Stress and Its Clinical Applications in Dementia
Mao, P. (2012) · Journal of Neurodegenerative Diseases · doi:10.1155/2013/319898 · Cited by 56
Does ionizing radiation influence Alzheimer's disease risk?
Begum, N., Wang, B., Mori, M., & Varès, G. (2012) · Journal of Radiation Research · doi:10.1093/jrr/rrs036 · Cited by 56
A Unified Hypothesis of Early- and Late-Onset Alzheimer’s Disease Pathogenesis
Atwood, C., & Bowen, R. L. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143210 · Cited by 56
Self-citationYagami, T., Yamamoto, Y., & Koma, H. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1277-4 · Cited by 56
A Proteomic Approach to Uncover Neuroprotective Mechanisms of Oleocanthal against Oxidative Stress
Giusti, L., Angeloni, C., Barbalace, M. C., Lacerenza, S., Ciregia, F., Ronci, M., Urbani, A., Manera, C., Digiacomo, M., Macchia, M., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082329 · Cited by 56
Plasma GSH levels and Alzheimer's disease. A prospective approach.: Results from the HELIAD study
Charisis, S., Ntanasi, E., Yannakoulia, M., Anastasiou, C. A., Kosmidis, M. H., Dardiotis, E., Hadjigeorgiou, G. M., Sakka, P., Veskoukis, A. S., Kouretas, D., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.10.027 · Cited by 56
The link between iron, metabolic syndrome, and Alzheimer’s disease
Grünblatt, E., Bartl, J., & Riederer, P. F. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0426-3 · Cited by 57
Apolipoprotein E as a β-amyloid-independent factor in Alzheimer’s disease
Wolf, A. B., Valla, J., Bu, G., Kim, J., LaDu, M., Reiman, E. M., & Caselli, R. J. (2013) · Alzheimer's Research & Therapy · doi:10.1186/alzrt204 · Cited by 55
Autophagy in Alzheimer’s disease
Moreira, P. I., Santos, R. X., Zhu, X., Lee, H.-G., Smith, M. A., Casadesus, G., & Perry, G. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.84 · Cited by 55
Self-citationAccelerating neuronal aging in in vitro model brain disorders: a focus on reactive oxygen species
Campos, P. B., Paulsen, B. S., & Rehen, S. K. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00292 · Cited by 55
Song, W., Zukor, H., Lin, S., Liberman, A., Tavitian, A., Mui, J., Vali, H., Fillebeen, C., Pantopoulos, K., Wu, T., et al. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07914.x · Cited by 56
Blair, J. A., McGee, H., Bhatta, S., Palm, R. F., & Casadesús, G. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00045 · Cited by 55
Chao, X., Chen, Z., Liu, A., He, X., Wang, S., Wang, Y., Liu, P., Ramassamy, C., Mak, S., Cui, W., et al. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12286 · Cited by 55
Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology
Guo, J., Cheng, J., North, B. J., & Wei, W. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.07.001 · Cited by 55
He, P., Yan, S., Wen, X., Zhang, S., Liu, Z., Liu, X., & Xiao, C. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28736 · Cited by 55
A Metabolic Basis for Alzheimer Disease
Perry, G. L., Nunomura, A., Raina, A. K., Aliev, G., Siedlak, S. L., Harris, P. L. R., Casadesús, G., Petersen, R. B., Bligh-Glover, W. Z., Balraj, E. K., et al. (2003) · Neurochemical Research · doi:10.1023/a:1025678510480 · Cited by 55
Self-citationIron overload-induced oxidative stress in myelodysplastic syndromes and its cellular sequelae
Kim, C. H., & Leitch, H. A. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103367 · Cited by 54
Sleep deficiency promotes Alzheimer's disease development and progression
Lv, Y.-N., Cui, Y., Zhang, B., & Huang, S.-M. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.1053942 · Cited by 54
The Role of Secretory Phospholipase A2 in the Central Nervous System and Neurological Diseases
Yagami, T., Yamamoto, Y., & Koma, H. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8565-9 · Cited by 54
Mitochondria in Aging and Alzheimer's Disease
Crouch, P. J., Cimdins, K., Duce, J. A., Bush, A. I., & Trounce, I. A. (2007) · Rejuvenation Research · doi:10.1089/rej.2007.0592 · Cited by 54
Boyko, A., Troyanova, N. I., Kovalenko, E. I., & Sapozhnikov, A. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122633 · Cited by 54
Sarchielli, P., Galli, F., Floridi, A., Floridi, A., & Gallai, V. (2003) · Amino Acids · doi:10.1007/s00726-003-0028-6 · Cited by 54
Cortical biochemistry in MCI and Alzheimer disease
Forman, M. S., Mufson, E. J., Leurgans, S. E., Praticò, D., Joyce, S. C., Leight, S., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Neurology · doi:10.1212/01.wnl.0000256373.39415.b1 · Cited by 54
Fukui, M., Choi, H. J., & Zhu, B. T. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.04.030 · Cited by 54
A novel anti-Alzheimer's disease drug, ladostigil
Weinreb, O., Amit, T., Bar‐Am, O., & Youdim, M. B. H. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-386467-3.00010-8 · Cited by 54
Effect of methionine-35 oxidation on the aggregation of amyloid-β peptide
Friedemann, M., Helk, E., Tiiman, A., Zovo, K., Palumaa, P., & Tõugu, V. (2015) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2015.07.017 · Cited by 53
He, X.-L., Zhou, W.-Q., Ming-gang, B., & Du, G. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.084 · Cited by 53
Barontini, M., Bernini, R., Carastro, I., Gentili, P., & Romani, A. (2013) · New Journal of Chemistry · doi:10.1039/c3nj01180a · Cited by 53
Evaluation of salivary heme oxygenase‐1 as a potential biomarker of early Parkinson's disease
Song, W., Kothari, V., Velly, A. M., Cressatti, M., Liberman, A., Gornitsky, M., & Schipper, H. M. (2018) · Movement Disorders · doi:10.1002/mds.27328 · Cited by 53
Chan, A., & Shea, T. B. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9405 · Cited by 53
Li, Y., Peng, P., Tang, L., Hu, Y., Hu, Y., & Sheng, R. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.07.009 · Cited by 53
Ferrer, I. (2004) · Neurotoxicity Research · doi:10.1007/bf03033283 · Cited by 53
Ghouzzi, V. E., Csaba, Z., Olivier, P., Lelouvier, B., Schwendimann, L., Dournaud, P., Verney, C., Rustin, P., & Gressèns, P. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318148b822 · Cited by 53
Ferrer, I. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.t01-1-00410.x · Cited by 52
Redox signaling and metabolism in Alzheimer's disease
Holubiec, M. I., Gellert, M., & Hanschmann, E.-M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1003721 · Cited by 53
Liu, Y., Shen, S., Li, Z., Jiang, Y., Si, J., Chang, Q., Liu, X., & Pan, R. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.08.007 · Cited by 52
Chiang, M., Nicol, C. J. B., Cheng, Y., Lin, K., Yen, C., & Lin, C. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.01.132 · Cited by 52
Bacon, E. R., & Brinton, R. D. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.040 · Cited by 52
Mehla, J., Singh, I., Diwan, D., Nelson, J. W., Lawrence, M., Lee, E., Bauer, A. Q., Holtzman, D. M., & Zipfel, G. J. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01293-5 · Cited by 52
Concepts for the treatment of Alzheimer's disease: molecular mechanisms and clinical application
Pietrzik, C. U., & Behl, C. (2005) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2005.00435.x · Cited by 52
Oxidative stress and hemorheological changes induced by acute treadmill exercise.
Ajmani, R. S., Fleg, J. L., Demehin, A. A., Wright, J. G., O'Connor, F., Heim, J. M., Tarien, E., & Rifkind, J. M. (2003) · PubMed · Cited by 52
The aging brain: less neurons could be better
Rutten, B. P. F. (2003) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(03)00002-2 · Cited by 52
Metadata
- Authors
- Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., Chiba, S., Atwood, C. S., Petersen, R. B., & Smith, M. A.
- Affiliations
- Asahikawa Medical University (JP)
- Case Western Reserve University (US)
- Takeda (Japan) (JP)
- Sensei Biotherapeutics (United States) (US)
- Kyoto University (JP)
- Corresponding author
- Nunomura, Akihiko
- ORCID
- Venue
- Journal of Neuropathology & Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-08
- Volume
- 60
- Issue
- 8
- Pages
- 759-767
- ISSN
- 0022-3069 (ISSN-L)
- 1554-6578
- OpenAlex
- W1542215809
- Cited by
- 1,885
- References
- 59
- Citations by year
- 2026: 46 · 2025: 31 · 2024: 52 · 2023: 61 · 2022: 80 · 2021: 98 · 2020: 86 · 2019: 82 · 2018: 69 · 2017: 73 · 2016: 70 · 2015: 83 · 2014: 86 · 2013: 86 · 2012: 104
- FWCI
- 33.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuropathology & Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- Asahikawa Medical University Collection and Research (Asahikawa Medical University) (submittedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Funders
- Alzheimer's Association
- National Institutes of Health (5r01ag009287-08, AG09287)
- Japan Society for the Promotion of Science (12670918)
- National Institute on Aging (AG-14249, R01AG014249, AG 09287)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, oxidative damage, 8-hydroxyguanosine, nitrotyrosine, amyloid plaques, neurofibrillary tangles, APOE ε4, disease progression, neurodegeneration, reactive oxygen species, RNA oxidation
- MeSH terms
- Aged, Alzheimer Disease, Apolipoproteins E, Brain, Female, Genotype, Guanosine, Heterozygote, Humans, Male, Middle Aged, Neurons, Tyrosine, Amyloid beta-Peptides, Neurofibrillary Tangles, Oxidative Stress, Disease Progression, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review